← Back to Search

CPAP Machine

Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea

N/A
Waitlist Available
Led By David A Ehrmann, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years

Summary

This trial looks at the effects of sleep problems on metabolism and hormones in women with PCOS.

Eligible Conditions
  • Polycystic Ovary Syndrome
  • Obstructive Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

3Treatment groups
Experimental Treatment
Group I: 3Experimental Treatment1 Intervention
Randomized to receive CPAP (continuous positive airway pressure) treatment for 6 weeks.
Group II: 1BExperimental Treatment1 Intervention
Randomized to receive depot Lupron for 6 weeks. Then randomized again to receive progesterone plus placebo for another 6 weeks.
Group III: 1AExperimental Treatment1 Intervention
Randomized to receive depot Lupron for 6 weeks. Then randomized again to receive estrogen plus placebo for another 6 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CPAP
2013
Completed Phase 3
~5460

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,058 Previous Clinical Trials
765,516 Total Patients Enrolled
1 Trials studying Polycystic Ovary Syndrome
37 Patients Enrolled for Polycystic Ovary Syndrome
Duke UniversityOTHER
2,458 Previous Clinical Trials
2,969,369 Total Patients Enrolled
2 Trials studying Polycystic Ovary Syndrome
154 Patients Enrolled for Polycystic Ovary Syndrome
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,061 Previous Clinical Trials
2,745,068 Total Patients Enrolled
35 Trials studying Polycystic Ovary Syndrome
5,767 Patients Enrolled for Polycystic Ovary Syndrome
David A Ehrmann, MDPrincipal InvestigatorUniversity of Chicago
~4 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top